Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sigmoid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Fractures, Bone 1Emergence Delirium 1Colonic Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroleptanalgesia × Gastrointestinal × Clear all
NCT05068180 2021-10-06

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

RenJi Hospital

Phase 4 Unknown
200 enrolled
GastrointestinalGenitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Stomach Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡